LULU vs PG: Which Is the Better Buy?
Side-by-side comparison of Lululemon Athletica Inc. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-21.
Lululemon Athletica Inc. · Consumer Cyclical
$98.06
+1.5% upside to fair value
Low Conviction
Grade C
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
PG has more upside to fair value
(+14.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LULU |
PG |
| Current Price |
$98.06 |
$147.04 |
| Fair Value Estimate |
$99.50 |
$168.19 |
| Upside to Fair Value |
+1.5%
|
+14.4%
|
| Market Cap |
$11.1B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
4.6x
|
17.6x
|
| Price / Sales |
1.0x
|
4.0x
|
| Price / FCF |
8.2x
|
22.4x
|
| Revenue Growth YoY |
-4.3%
|
+1.5%
|
| Gross Margin |
56.1%
|
50.2%
|
| Operating Margin |
17.8%
|
22.7%
|
| Return on Equity |
29.7%
|
29.8%
|
| Dividend Yield |
0% |
2.92% |
| FCF Yield |
12.24%
|
4.47%
|
| Analyst Consensus |
Sell
|
Buy
|
Investment Thesis
Lululemon Athletica designs and retails premium athletic apparel and accessories through company-owned stores and direct-to-consumer channels, with roughly 39,000 employees and a brand built on technical fabrics and community-led fitness positioning. The business still earns high returns on equity of 29.7% and generates $12.00 of free cash flow per share on $97.70 of revenue per share, with TTM g…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
LULU |
PG |
| Zone Low |
$74.62 |
$126.14 |
| Zone High |
$84.58 |
$142.96 |
| In Buy Zone? |
No
|
No
|